Streptococcus suis, an Emerging Drug-Resistant Animal and Human Pathogen by Claudio Palmieri et al.
MINI REVIEW ARTICLE
published: 25 November 2011
doi: 10.3389/fmicb.2011.00235
Streptococcus suis, an emerging drug-resistant animal and
human pathogen
Claudio Palmieri , Pietro E.Varaldo and Bruna Facinelli*
Section of Microbiology, Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy
Edited by:
Stefania Stefani, University of
Catania, Italy
Reviewed by:
Fiona Walsh, Agroscope Changins
Wädenswil, Switzerland
Bruno Gonzalez-Zorn, Universidad
Complutense de Madrid, Spain
*Correspondence:
Bruna Facinelli , Section of
Microbiology, Department of
Biomedical Sciences and Public
Health, Polytechnic University of
Marche, Via Tronto 10/A, 60126
Ancona, Italy.
e-mail: b.facinelli@univpm.it
Streptococcus suis, a major porcine pathogen, has been receiving growing attention not
only for its role in severe and increasingly reported infections in humans, but also for its
involvement in drug resistance. Recent studies and the analysis of sequenced genomes
have been providing important insights into the S. suis resistome, and have resulted in the
identiﬁcation of resistance determinants for tetracyclines, macrolides, aminoglycosides,
chloramphenicol, antifolate drugs, streptothricin, and cadmium salts. Resistance gene-
carrying genetic elements described so far include integrative and conjugative elements,
transposons, genomic islands, phages, and chimeric elements. Some of these elements
are similar to those reported in major streptococcal pathogens such as Streptococcus
pyogenes, Streptococcus pneumoniae, and Streptococcus agalactiae and share the same
chromosomal insertion sites.The available information strongly suggests that S. suis is an
important antibiotic resistance reservoir that can contribute to the spread of resistance
genes to the above-mentioned streptococci. S. suis is thus a paradigmatic example of
possible intersections between animal and human resistomes.
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The massive use of antibiotics by the livestock industry, either
for growth promotion (a practice recently banned in Europe) or
for prophylaxis and therapy, contributed to the emergence, and
spread of antibiotic resistance (McEwen and Fedorka-Cray, 2002).
Antimicrobials for veterinary use are the same or belong to the
same classes as those for human use and exert a constant pressure
on the animal microﬂora, selecting for resistance (Witte, 1997).
Streptococcus suis, an emerging zoonotic pathogen,has been receiv-
ing growing attention for its involvement not only in severe and
increasingly reported human infections, but also in drug resis-
tance. Here we outline the current knowledge about the S. suis
resistome and assess its role as a possible reservoir of antibiotic
resistance determinants for streptococcal pathogens.
S. SUIS AND S. SUIS INFECTIONS
Streptococcus suis is amajor porcine pathogenworldwide, endemic
in all countries where intensive pig farming is practiced. More-
over, it is increasingly being isolated from mammalian species
other than pigs, frombirds, and from the environment (Gottschalk
et al., 2010). In humans, S. suis is now considered as an emerging
zoonotic pathogen, causing systemic infection: meningitis with
possible residual deafness or vestibular dysfunctions is the most
frequent clinical presentation; endocarditis, cellulitis, peritonitis,
rhabdomyolysis, arthritis, spondylodiscitis, pneumonia, uveitis,
and endophthalmitis have also been reported (Lun et al., 2007;
Wertheim et al., 2009a). The human infection is mainly an occu-
pational disease that may affect those who come into contact with
animal infected bloodor secretions orwith pork-derived products.
Thirty-three capsular serotypes are currently recognized (Staats
et al., 1997; Hill et al., 2005). Serotype 2 is the most virulent and
is responsible for severe infections in both swine and humans
worldwide.
After the ﬁrst reported human case of S. suis infection in
Denmark in 1968 (Perch et al., 1968), sporadic cases (mainly of
meningitis) have been reported in Europe and South-East Asia in
the following decades (Lun et al., 2007; Wertheim et al., 2009a). In
2005, a severe epidemic caused by S. suis serotype 2 broke out in
China’s Sichuan Province, preceded by a small outbreak in 1998
(Yu et al., 2006). From 2005 onward, an increasing number of
S. suis human infections have been reported worldwide, also in
countries where the infection had been rarely or never reported
before (Gottschalk et al., 2010). Currently, the majority of cases
occur in South-East Asia where S. suis is a leading cause of adult
meningitis, in particular in Vietnam (Mai et al., 2008; Wertheim
et al., 2009b). A multilocus sequence typing scheme (King et al.,
2002) disclosed a high genetic diversity of S. suis isolates with
over 250 sequence types (ST) identiﬁed (http://ssuis.mlst.net).
Four major ST clonal complexes (CC; CC–ST1, CC–ST16, CC–
ST25, and CC–ST27) dominate the population; CC–ST1, the most
virulent, includes ST1, found throughout the world, and ST7,
responsible for the Chinese epidemic (Ye et al., 2006). It has been
suggested that the increase in human cases may also reﬂect the
recent awareness of S. suis as an emerging agent of meningitis
and the improvement of microbiological diagnostic techniques
(Gottschalk et al., 2010). Actually, the fact that S. suis does share
several characteristics with other bacteria causing meningitis can
result in misdiagnosis. Indeed, many isolates that had originally
been identiﬁed as Streptococcus pneumoniae, enterococci, Strep-
tococcus bovis, viridans streptococci, or even Listeria spp. were
re-identiﬁed as S. suis in retrospective studies. In addition, recent
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serologic data suggest that human infection occurs more fre-
quently than previously believed (Smith et al., 2008). Altogether
these ﬁndings suggest that S. suis disease has been under diag-
nosed in the past. The growing interest in this pathogen is reﬂected
by recent (2007–2011) whole-genome sequencing studies. So far,
eight strains have been sequenced (Chen et al., 2007; Holden et al.,
2009; Ye et al., 2009; Hu et al., 2011a,b), showing that ∼40% of
the∼2Mb genome is unique. This suggests that S. suis is phyloge-
netically distinct from other Streptococcus species whose genome
sequences are currently available. Intraspecies genomic compar-
isons have shown high levels of sequence conservation. However,
these data may be inﬂuenced by the clonal relatedness of the
sequenced strains, six of eight being serotype 2 strains belonging
to the CC–ST1.
CURRENT KNOWLEDGE OF THE S. SUIS RESISTOME
High rates of S. suis resistance to tetracyclines (up to >90%) and
macrolides (up to>70%) have been reported in pig isolates world-
wide (Wisselink et al., 2006; Hendriksen et al., 2008; Zhang et al.,
2008; Princivalli et al., 2009). In the 1990s, a retrospective study
of historic pig isolates in Denmark demonstrated that the increase
in tetracycline and macrolide resistance had begun in the early
1980s (Aarestrup et al., 1998). Resistances to tetracyclines and
macrolides in human strains were ﬁrst reported in the second
half of the ﬁrst decade of 2000, but retrospective studies showed
that they were already widespread in previous decades (Ye et al.,
2008; Chu et al., 2009; Hoa et al., 2011). The genetic basis of tetra-
cycline and macrolide resistance in S. suis has been extensively
investigated.
Tetracycline resistance in streptococci is mainly due to ribo-
somal protection genes tet (M) and tet (O), and less frequently
tet (Q), tet (T), and tet (W), and to efﬂux genes tet (K) and tet (L)
(Chopra and Roberts, 2001; Roberts, 2005). Until a few years ago,
tet (M) and tet (O) were the only tetracycline resistance deter-
minants reported in S. suis; further determinants have lately
been detected, such as ribosomal protection genes tet (W) and
mosaic tet (O/W/32/O) and efﬂux genes tet (L), tet (B), and tet (40).
Of these, tet (O/W/32/O), tet (B), and tet (40) had never been
described in the genus Streptococcus before. tet (W) is an emerging
tetracycline resistance determinant whose host range, including
Gram-positive and Gram-negative, aerobic and anaerobic bacte-
ria, is second only to that of tet (M) among ribosomal protection
tet genes (Roberts, 2005). In S. suis, tet (W) was ﬁrst detected
in 2008, in an isolate from a case of meningitis in Italy (ST1
strain SsCA) (Manzin et al., 2008); it was subsequently described
in other Italian strains (ST1 human strain SSUD and three pig
isolates) (Princivalli et al., 2009), in the sequenced genome of the
Chinese ST1 human strain GZ1 (Ye et al., 2009), and in two Viet-
namese human isolates (Hoa et al., 2011). tet (O/W/32/O) is a
new mosaic gene reported in 2009 in clonally unrelated pig iso-
lates of S. suis (Princivalli et al., 2009). Mosaic tet genes are a
recently discovered class of hybrids of ribosomal protection genes
(Thaker et al., 2010). Mosaic derivatives of tet (O) and tet (W)
were ﬁrst detected in 2003 in anaerobic Gram-negative Megas-
phaera elsdenii from swine intestine (Stanton and Humphrey,
2003).Othermosaic genes, also including portions of tet (32),were
later detected in Clostridium difﬁcile (Patterson et al., 2007) and
Clostridium saccharolyticum (Kazimierczak et al., 2008). tet (L),
commonly carried in streptococci by small transmissible plas-
mids (Chopra and Roberts, 2001), has recently been detected in a
sequenced genome of S. suis, where it is carried by a Tn916-like
element (Holden et al., 2009), and lately, still outside plasmids, in
Vietnamese human isolates (Hoa et al., 2011). tet (B), which had
never been described in Gram-positive bacteria, was detected in
2010 inChinese pig isolates of S. suis (Chander et al., 2011). tet (40)
is a novel efﬂux gene recently detected in C. saccharolyticum in
tandem with a mosaic tet gene [tet (O/32/O)] (Kazimierczak et al.,
2008).
Macrolide resistance in streptococci ismainly due tomethylase-
mediated target site modiﬁcation by erm genes and to active efﬂux
by mef genes. erm(B), the old-established erm determinant in
streptococci, can be expressed either constitutively or inducibly
and is usually associated with high-level resistance; erm(TR),
an erm(A) subclass, is normally inducible and is widely distrib-
uted in S. pyogenes isolates; erm(T) was detected in inducibly
erythromycin-resistant isolates of group D streptococci and in
S. pyogenes (Varaldo et al., 2009), and more recently in Strep-
tococcus dysgalactiae subsp. equisimilis (Palmieri et al., 2011b).
mef-class genes, which include some variants, are associated to
a low-level resistance pattern affecting, among MLS antibiotics,
only 14- and 15-membered macrolides (M phenotype) (Sutcliffe
et al., 1996). mef(A) and mef(E) are widespread in S. pyogenes
and S. pneumoniae, respectively, but they are also common in
other streptococcal species (Varaldo et al., 2009). In S. suis, while
mef(A) (Martel et al., 2003; Chu et al., 2009) and mef(E) (Hu et al.,
2011a,c) have only occasionally been reported, erm(B) is found
in >90% of macrolide-resistant pig isolates (Martel et al., 2001,
2003; Princivalli et al., 2009; Hoa et al., 2011); it has recently been
reported also in human isolates (Manzin et al., 2008; Holden et al.,
2009; Princivalli et al., 2009; Hoa et al., 2011). Although no fur-
ther macrolide resistance determinants have been documented,
the isolation of macrolide-resistant strains negative for the above
genes (Martel et al., 2003; Princivalli et al., 2009; Hoa et al., 2011)
suggests that other genetic determinants or target site mutations
may occur.
Strains resistant to other antibiotics, such as β-lactams, amino-
glycosides, trimethoprim–sulfamethoxazole, chloramphenicol,
and ﬂuoroquinolones, have been reported. The genetic basis of
resistance to these antibiotics has only occasionally been investi-
gated. Penicillin resistance was ﬁrst reported in a human isolate in
UK in 1980 (Shneerson et al., 1980) and more recently among
pig isolates (Marie et al., 2002; Higgins and Gottschalk, 2005;
Huang et al., 2005; Zhang et al., 2008). Penicillin-binding pro-
tein modiﬁcations (altered molecular weight and/or decreased
afﬁnity for penicillin) are involved in the resistance mecha-
nism (Cain et al., 1995). Quite recently, resistance also to third-
generation cephalosporins has been reported (Hu et al., 2011c).
Aminoglycoside resistance has frequently been reported in S.
suis (Touil et al., 1988; Wasteson et al., 1994; Marie et al.,
2002; Tian et al., 2004; Wisselink et al., 2006; Hendriksen
et al., 2008). Recently, genes coding for resistance to kanamycin
[aminoglycoside-3′-phosphotransferase (aphA)] and to strepto-
mycin [aminoglycoside-6′-adenyltransferase (aadE)] have been
detected in multiresistant strains (Chen et al., 2007; Holden
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et al., 2009; Hu et al., 2011a; Palmieri et al., 2011a). Resis-
tance to antifolate drugs has frequently been reported (Mengel-
ers et al., 1989; Wisselink et al., 2006; Zhang et al., 2008). A
dihydrofolate reductase (dhfr) resistance gene has been detected
in the sequenced strain BM407 (Holden et al., 2009). Chloram-
phenicol resistance has rarely been reported (Takamatsu et al.,
2003). However, a recent increase in chloramphenicol-resistant
strains has been noted among human isolates in Vietnam (Hoa
et al., 2011). Fluoroquinolone resistance has occasionally been
described (Aarestrup et al., 1998; Escudero et al., 2007, 2011; Hen-
driksen et al., 2008; Hu et al., 2011c). Resistance is associated with
single point mutations in the quinolone resistance-determining
regions of ParC and GyrA (Escudero et al., 2007; Hu et al., 2011c),
but a novel efﬂux pump has recently been described (Escudero
et al., 2011).
CONTRIBUTION OF EXOGENOUS GENETIC ELEMENTS TO
THE S. SUIS RESISTOME
Recent studies (Li et al., 2011; Palmieri et al., 2011a,c) and
the analysis of sequenced genomes (Chen et al., 2007; Holden
et al., 2009; Ye et al., 2009; Hu et al., 2011a,b,c) have pro-
vided signiﬁcant insights into the S. suis resistome, leading to
the identiﬁcation of several genetic elements carrying resistance
determinants for tetracyclines,macrolides, aminoglycosides, chlo-
ramphenicol, antifolate drugs, streptothricin, and cadmium salts.
These elements, that include integrative and conjugative ele-
ments (ICEs), transposons, genomic islands (GIs), phages, and
chimeric elements, are illustrated in Figure 1. A scheme of their
integration sites into the S. suis core chromosome is shown in
Figure 2.
Five ICEs have been described in the sequenced genomes of
ST7 (98HAH33, 05ZYH33, and SC84) and ST1 (BM407) human
strains (Chen et al., 2007; Holden et al., 2009). Of these, four –
ICESsu98HAH33, ICESsu05ZYH33, and ICESsuSC84 (∼90 kb, three vir-
tually identical elements), and ICESsuBM407.2 (∼80 kb) – are closely
related, except for cargo genes, to ICESde3396 of S. dysgalactiae
subsp. equisimilis (Davies et al., 2009): they are integrated imme-
diately downstream of the 50S ribosomal gene L7/L12 (rplL), they
harbor a tyrosine family integrase, and share an almost identi-
cal set of genes for the conjugative machinery. ICESsu98HAH33,
ICESsu05ZYH33, and ICESsuSC84 bear three distinct cargo regions:
(i) a putative bacteriocin biosynthesis cluster that is disrupted by
a putative integron containing the aadE gene; (ii) a Tn916 trans-
poson, regularly carrying tet (M); and (iii) a cluster of genes asso-
ciated with lantibiotic export/resistance. ICESsuBM407.2 contains
three distinct cargo regions: (i) a Tn916-like element carrying,
FIGURE 1 | ORF maps and genome organization of recognized
S. suis genetic elements carrying resistance genes. ICESsuSC84 was
chosen as a representative of the ICEs of ST7 strains. The ORFs,
indicated as‘arrows pointing in the direction of transcription, are
depicted as white arrows, except for resistance genes which are speciﬁed in
the box. Cargo regions are enclosed in rounded rectangles. Gray areas
between ORF maps denote >90% DNA identity (identities between cargo
regions are not shown).
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besides tet (M), tet (L) and a novel chloramphenicol acetyltrans-
ferase (cat ) gene; (ii) a multiresistance fragment bearing tet (O),
erm(B), and a dhfr gene; and (iii) a lantibiotic cluster similar
to the one mentioned above. The ﬁfth ICE (ICESsuBM407.1) dis-
plays a similar scaffold but contains a different integrase, belong-
ing to serine recombinase family, which directs the insertion of
this element into a luciferase-like monooxygenase gene (Holden
et al., 2009). ICESsuBM407.1 contains two cargo regions: (i) a Tn916
transposon, regularly carrying tet (M), and (ii) a lactose utiliza-
tion cluster. Structural and compositional analysis strongly sug-
gests that all ﬁve ICEs have the potential to undergo excision
and transfer. In particular, ICESsu05ZYH33 was transferred at high
frequency to S. suis recipients in conjugation assays (Li et al.,
2011). Another ICE (ICESsu32457, ∼56 kb), recently identiﬁed in
a pig isolate in Italy and shown to carry tet (O/W/32/O), is the
ﬁrst reported genetic support for a mosaic tet gene in strep-
tococci (Palmieri et al., 2011c). ICESsu32457 is transferable to S.
suis, S. pyogenes, S. agalactiae, and S. pneumoniae, and similar
to ICESsu98HAH33, ICESsu05ZYH33, ICESsuSC84, and ICESsuBM407.2
mentioned above, it is closely related to ICESde3396 of S. dys-
galactiae subsp. equisimilis except for cargo genes (Palmieri et al.,
submitted).
A tet (W)-carrying∼47 kb GI (here designated GIGZ1), located
immediately downstream of the lysyl-tRNA synthetase chromo-
somal gene (lysS), has been identiﬁed in the sequenced genome
of the Chinese strain GZ1 (Ye et al., 2009). An almost identi-
cal, non-transferable, tet (W)-carrying GI (GISsCA), differing from
GIGZ1 only for the presence of an erm(B)-containing insertion,
has recently been detected in an Italian human strain (Palmieri
et al., 2011a).
In another Italian human strain, the presence of tet (W)
has been reported in a phage (ϕSsUD.1, ∼61 kb) (Palmieri
et al., 2011a). ϕSsUD.1 carries a unique combination of antibi-
otic and heavy metal resistance genes resulting from the pres-
ence, besides tet (W), of an erm(B)-containing MAS (macrolide–
aminoglycoside–streptothricin) – like fragment and a cadC/cadA
cadmium efﬂux cassette. The MAS-like fragment closely resem-
bles the one recently described in the pneumococcal transposons
Tn6003 and Tn1545 (Cochetti et al., 2007, 2008). The resistance
genes ﬁtting in the ϕSsUD.1 phage scaffold differ from, but are
in the same position as, the cargo genes carried by S. pyogenes
phages such as ϕ10394.4 (Banks et al., 2003) and ϕm46.1 (Bren-
ciani et al., 2010).ϕSsUD.1 is integrated at the 3′ endof a conserved
RNA uracil methyltransferase (rum) gene and is transferable to S.
pyogenes.
A ∼124 kb chimeric element constituted of two portions, an
ICE (∼69 kb) and a phage (∼55 kb), has recently been detected
in the sequenced genome of JS14 (Hu et al., 2011a), integrated
at the 3′ end of the rum gene. The ICE portion harbors a site-
speciﬁc integrase, it displays a scaffold similar to the S. suis ICEs
mentioned above, and contains two cargo regions, one bearing
tet (O) in tandem with tet (40) and the other a bacteriocin gene
cluster. The phage portion displays the typical modular organiza-
tion of tailed phages, and closely resembles ϕSsUD.1 (Palmieri
et al., 2011a). The right end of the phage portion bears an
erm(B)-containing MAS-like fragment, like ϕSsUD.1; the left end
bears a mega-like genetic structure, similar to the mef(E)-carrying
FIGURE 2 | Schematic illustration showing the S. suis core
chromosome with the insertion sites of recognized genetic elements
carrying resistance genes.
mega element originally described in S. pneumoniae (Gay and
Stephens, 2001), in the same position as the cadC/cadA cassette in
ϕSsUD.1.
Beside the Tn916-family elements, only another transposon
carrying resistance genes, TnSs1, has been described in S. suis
(Takamatsu et al., 2003). It contains a cat gene showing 97%
identity with catPC194 (Widdowson et al., 2000) ﬂanked by direct
repeats of an IS6-family element.
CONCLUDING REMARKS
Although the emergence of S. suis as a human pathogen has caused
a ﬂurry of research, current knowledge on the S. suis resistome
is still fairly sketchy. This is mainly due to the so far limited
number of studies of the genetic basis of resistance and to the
redundancy of data from the strains sequenced, many of which
are clonally related. Next-generation DNA sequencing will proba-
bly provide awealth of newdata in the next few years. The available
information suggests that S. suis may contribute to the spread of
antibiotic resistance genes to streptococcal human pathogens such
as S. pyogenes, S. pneumoniae, and S. agalactiae, acting as a resis-
tance reservoir. The notion is supported by studies demonstrating
that S. suis harbors mobile resistance genetic elements, similar to
those of the above-mentioned streptococci, that share the same
conserved chromosomal insertion sites. Thus, S. suis is a para-
digmatic example of possible intersections between animal and
human resistomes.
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